1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Amoy Diagnostics Co., Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2008

Location

Xiamen Fujian China

Primary Industry

Medical Devices & Equipment

About

Established in 2008 and based in Xiamen, China, Amoy Diagnostics Co., Ltd. is a biotechnology company that focuses on the development of molecular diagnostics for oncology precision medicine.
Current Investors
Qiming Venture Partners, QM18, Grains Valley Venture Capital

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment, Medical Equipment Distributors, Pharmaceuticals
Website
www.amoydiagnostics.com
Company Stage
Mature
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2014
106,810,760
-
16,904,175
15.8%
30,526,200
28.6%
19,138,943
17.9%
31 Dec 2015
176,877,645
65.6%
19,310,085
10.9%
40,997,900
23.2%
18,488,513
10.5%
31 Dec 2016
252,987,005
43%
59,949,070
23.7%
90,085,000
35.6%
65,464,923
25.9%
31 Dec 2017
329,954,069
30.4%
110,033,993
33.3%
127,397,642
38.6%
94,065,765
28.5%
31 Dec 2018
438,212,593
32.8%
138,748,148
31.7%
159,477,710
36.4%
126,737,915
28.9%
31 Dec 2019
31 Dec 2020
31 Dec 2021

Unlock the recent years of financials and more for Amoy Diagnostics Co., Ltd..

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.